The store will not work correctly when cookies are disabled.
N-tert-butyl-2-oxo-3-(2-oxopyrrolidin-1-yl)indoline-3-carboxamide
ID: ALA4874271
PubChem CID: 164628444
Max Phase: Preclinical
Molecular Formula: C17H21N3O3
Molecular Weight: 315.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)NC(=O)C1(N2CCCC2=O)C(=O)Nc2ccccc21
Standard InChI: InChI=1S/C17H21N3O3/c1-16(2,3)19-15(23)17(20-10-6-9-13(20)21)11-7-4-5-8-12(11)18-14(17)22/h4-5,7-8H,6,9-10H2,1-3H3,(H,18,22)(H,19,23)
Standard InChI Key: HZNAUNXYJPJPMT-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
39.1757 -22.0931 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.3820 -22.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2840 -23.2197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2828 -24.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9620 -24.3946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9602 -22.8315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6399 -23.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6402 -24.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3860 -24.2481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.8491 -23.6108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6332 -23.6106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.0878 -22.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7617 -21.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2938 -20.6338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4146 -20.8402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3394 -21.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5668 -22.2073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.0832 -21.7423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.8761 -22.7699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.4534 -22.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2429 -22.4024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2412 -21.4024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0276 -21.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 2 0
4 5 1 0
5 8 2 0
7 6 2 0
6 3 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 2 1 0
2 7 1 0
10 11 2 0
2 12 1 0
1 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 1 1 0
16 17 2 0
12 18 2 0
12 19 1 0
19 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.37 | Molecular Weight (Monoisotopic): 315.1583 | AlogP: 1.37 | #Rotatable Bonds: 2 |
Polar Surface Area: 78.51 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.16 | CX Basic pKa: ┄ | CX LogP: 0.85 | CX LogD: 0.85 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.81 | Np Likeness Score: -0.24 |
References
1. Brandão P, López Ó, Leitzbach L, Stark H, Fernández-Bolaños JG, Burke AJ, Pineiro M.. (2021) Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors., 12 (11.0): [PMID:34795859] [10.1021/acsmedchemlett.1c00344] |